Vanguard Portfolio Management
COGT icon

Vanguard Portfolio Management’s Cogent Biosciences COGT Stock Holding History

Vanguard Portfolio Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$260M Buy
8,131,026
+58,615
+0.7% +$2.17M 0.01% 1020
2026
Q2 		$312M Buy
8,072,411
+739,078
+10% +$25.9M 0.01% 959
2026
Q1 		$282M Buy
+7,333,333
New +$271M 0.01% 927

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Vanguard Portfolio Management's COGT Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Cogent Biosciences (COGT) stake by 0.73% in Q3 2026, buying an estimated $2.17M and bringing the position to 8,131,026 shares worth $260M. The position accounts for 0.01% of the portfolio, ranked #1020.

Vanguard Portfolio Management first reported a position in COGT in Q1 2026 and has held it in 3 quarters since. The position peaked at $312M in Q2 2026. 202 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Vanguard Portfolio Management held 8,131,026 shares of Cogent Biosciences worth $260M as of Q3 2026.
  • Vanguard Portfolio Management bought 58,615 Cogent Biosciences shares in Q3 2026, an estimated $2.17M.
  • Cogent Biosciences made up 0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1020 holding.
  • Vanguard Portfolio Management first reported a position in Cogent Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Cogent Biosciences position peaked at $312M in Q2 2026.
  • 202 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.